SREBF1 and metabolic dysfunction-associated steatotic liver disease: For NAFLD, genetically predicted higher levels of ARNTL and SREBF1 were associated with a decreased risk of NAFLD and were mutually confirmed in three cohorts (Fig. 7A and Table S11).